CERS
Price
$1.89
Change
+$0.10 (+5.59%)
Updated
Mar 28, 6:59 PM EST
34 days until earnings call
CUTR
Price
$1.47
Change
+$0.08 (+5.76%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
Ad is loading...

Compare trend and price CERS vs CUTR

Header iconCERS vs CUTR Comparison
Open Charts CERS vs CUTRBanner chart's image
Cerus
Price$1.89
Change+$0.10 (+5.59%)
Volume$651.54K
CapitalizationN/A
Cutera
Price$1.47
Change+$0.08 (+5.76%)
Volume$769.39K
CapitalizationN/A
View a ticker or compare two or three
CERS vs CUTR Comparison Chart

Loading...

CERSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CUTRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CERS vs. CUTR commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and CUTR is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (CERS: $1.89 vs. CUTR: $1.47)
Brand notoriety: CERS and CUTR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 67% vs. CUTR: 86%
Market capitalization -- CERS: $342.62M vs. CUTR: $29.34M
CERS [@Medical Specialties] is valued at $342.62M. CUTR’s [@Medical Specialties] market capitalization is $29.34M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileCUTR’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • CUTR’s FA Score: 1 green, 4 red.
According to our system of comparison, CERS is a better buy in the long-term than CUTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while CUTR’s TA Score has 3 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 5 bearish.
  • CUTR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both CERS and CUTR are a bad buy in the short-term.

Price Growth

CERS (@Medical Specialties) experienced а -3.08% price change this week, while CUTR (@Medical Specialties) price change was -36.09% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

CERS is expected to report earnings on May 02, 2024.

CUTR is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for CERS with price predictions.
OPEN
A.I.dvisor published
a Summary for CUTR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CERS($343M) has a higher market cap than CUTR($29.3M). CERS YTD gains are higher at: -12.500 vs. CUTR (-58.298). CERS has higher annual earnings (EBITDA): -26.34M vs. CUTR (-59.84M). CUTR has more cash in the bank: 223M vs. CERS (65.9M). CERS has less debt than CUTR: CERS (96M) vs CUTR (431M). CUTR has higher revenues than CERS: CUTR (246M) vs CERS (156M).
CERSCUTRCERS / CUTR
Capitalization343M29.3M1,171%
EBITDA-26.34M-59.84M44%
Gain YTD-12.500-58.29821%
P/E RatioN/A434.78-
Revenue156M246M63%
Total Cash65.9M223M30%
Total Debt96M431M22%
FUNDAMENTALS RATINGS
CERS vs CUTR: Fundamental Ratings
CERS
CUTR
OUTLOOK RATING
1..100
6358
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6497
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
5027

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (49) in the Medical Specialties industry is somewhat better than the same rating for CUTR (94). This means that CERS’s stock grew somewhat faster than CUTR’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CUTR (100). This means that CERS’s stock grew similarly to CUTR’s over the last 12 months.

CERS's SMR Rating (97) in the Medical Specialties industry is in the same range as CUTR (100). This means that CERS’s stock grew similarly to CUTR’s over the last 12 months.

CERS's Price Growth Rating (64) in the Medical Specialties industry is somewhat better than the same rating for CUTR (97). This means that CERS’s stock grew somewhat faster than CUTR’s over the last 12 months.

CUTR's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for CERS (100). This means that CUTR’s stock grew significantly faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSCUTR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
CERSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CUTRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNAX21.460.05
+0.23%
MFS Equity Income A
NSBCX58.760.12
+0.20%
Nuveen Dividend Growth C
RYAMX23.20N/A
N/A
Guggenheim Long Short Equity A
PGRRX43.44N/A
N/A
Pioneer Select Mid Cap Growth R
CAMIX25.67-0.03
-0.12%
Cambiar International Equity Inv

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ATRC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ATRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+5.59%
ATRC - CERS
55%
Loosely correlated
+0.90%
TWST - CERS
50%
Loosely correlated
-0.49%
KIDS - CERS
49%
Loosely correlated
+0.79%
CDNA - CERS
46%
Loosely correlated
+0.57%
TFX - CERS
44%
Loosely correlated
+1.03%
More

CUTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUTR has been loosely correlated with TWST. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CUTR jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUTR
1D Price
Change %
CUTR100%
+5.76%
TWST - CUTR
41%
Loosely correlated
-0.49%
TMCI - CUTR
40%
Loosely correlated
+5.58%
WRBY - CUTR
39%
Loosely correlated
+2.72%
NVST - CUTR
38%
Loosely correlated
-0.79%
CERS - CUTR
38%
Loosely correlated
+5.59%
More